TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32253271

Group type: EXPERIMENTAL
Intervention: High-dose IV iron
Number of subjects: 2141

Group type: COMPARATOR
Intervention: Low-dose IV iron
Number of subjects: 2141
Study: 34158778

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (2 gr) over 30 minutes
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline over 30 minutes (Control)
Number of subjects: 60
Study: 32517660

Group type: EXPERIMENTAL
Intervention: Natural rectal progesterone (800 mg daily)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199
Study: 34704645

Group type: EXPERIMENTAL
Intervention: Low ageing awareness and high positive control (LAPC)
Number of subjects: 902

Group type: EXPERIMENTAL
Intervention: High ageing awareness and negative control (HANC)
Number of subjects: 902

Group type: EXPERIMENTAL
Intervention: Low positive consequences and control (LPCC)
Number of subjects: 902
Study: 34987601

Group type: EXPERIMENTAL
Intervention: Ultrasonic elastography combined with HPV detection using the bilateral filter intelligent denoising algorithm
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ultrasonic elastography combined with HPV detection without optimization
Number of subjects: 100
Study: 32202593

Group type: EXPERIMENTAL
Intervention: Sleep-Disordered Breathing (SDB)
Number of subjects: 127
Study: 34241801

Group type: EXPERIMENTAL
Intervention: Buxue Yimu Pills (BYP, 24 g/d)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Ferrous sulfate (FS Tablets, 0.9 g/d)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Combination of BYP and FS (BYP, 24 g/d plus FS Tablets, 0.9 g/d)
Number of subjects: 150
Study: 32842249

Group type: EXPERIMENTAL
Intervention: Double-tube epidural block group (n=108)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Single-tube epidural block group (n=108)
Number of subjects: 216
Study: 35228755

Group type: EXPERIMENTAL
Intervention: Nivolumab and ipilimumab with CBM588
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nivolumab and ipilimumab without CBM588
Number of subjects: 30
Study: 36047609

Group type: EXPERIMENTAL
Intervention: Self-evaluation of foetal movement and position tracking
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 34531204

Group type: EXPERIMENTAL
Intervention: Ross procedure
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional AVR (mechanical vs stented or stentless bioprosthesis)
Number of subjects: 60
Study: 36320165

Group type: EXPERIMENTAL
Intervention: Lexical Association Technique
Number of subjects: 63

Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 63
Study: 33852752

Group type: EXPERIMENTAL
Intervention: fampridine
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: amantadine
Number of subjects: 45

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 45
Study: 35235002

Group type: EXPERIMENTAL
Intervention: Fingolimod-discontinuation group
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fingolimod-continuation group
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 34591548

Group type: EXPERIMENTAL
Intervention: Transference-focused psychotherapy (TFP)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Dialectical behavior therapy (DBT)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Supportive psychodynamic therapy (SPT)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 88
Study: 34328040

Group type: EXPERIMENTAL
Intervention: Familiar sender
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unfamiliar sender
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Familiar sender (nationwide survey)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unfamiliar sender (nationwide survey)
Number of subjects: 0
Study: 32319006

Group type: EXPERIMENTAL
Intervention: BZD tapering
Number of subjects: 84

Group type: COMPARATOR
Intervention: Pharmaceutical GHB tapering
Number of subjects: 84
Study: 32233711

Group type: EXPERIMENTAL
Intervention: Capillary index score system
Number of subjects: 157
Study: 35817643

Group type: EXPERIMENTAL
Intervention: 3 sessions of radial extracorporeal shockwave therapy (rESWT)
Number of subjects: 117

Group type: COMPARATOR
Intervention: minimal-dose rESWT
Number of subjects: 117
Study: 34791307

Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 99

Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 99

Group type: COMPARATOR
Intervention: Oxacillin
Number of subjects: 99

Group type: COMPARATOR
Intervention: Flucloxacillin
Number of subjects: 99
Study: 34156308

Group type: EXPERIMENTAL
Intervention: Rollover abdominal paracentesis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard abdominal paracentesis
Number of subjects: 0
Study: 33327260

Group type: EXPERIMENTAL
Intervention: Far-infrared irradiation (FIR) for 40 minutes
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 44
Study: 33382448

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (3×1000 mg/day, 0.5 mEq/kg)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Sodium chloride (2×1000 mg/day)
Number of subjects: 45

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 45
Study: 34864757

Group type: EXPERIMENTAL
Intervention: Individualized-Targeted Cognitive Training (20 hours total, 10 hours per two selected cognitive domains)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Immediate and delayed spatial learning and memory training
Number of subjects: 109

Group type: COMPARATOR
Intervention: No-contact control group
Number of subjects: 109
Study: 33060126

Group type: EXPERIMENTAL
Intervention: BATHE interview technique
Number of subjects: 138

Group type: COMPARATOR
Intervention: Usual interview technique (Control)
Number of subjects: 138
Study: 35146628

Group type: EXPERIMENTAL
Intervention: Interactive video
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Screencast
Number of subjects: 135

Group type: COMPARATOR
Intervention: Text-based resource
Number of subjects: 135
Study: 35775838

Group type: EXPERIMENTAL
Intervention: Estimated one-repetition maximum (1-RM)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Isokinetic peak strength
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: 6-minute walk test (6MWT)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Get Up and Go test (GUG)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Stair-climb test
Number of subjects: 177
Study: 34301751

Group type: EXPERIMENTAL
Intervention: Ramucirumab (10 mg/kg) plus Erlotinib (150 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus Erlotinib (150 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both treatment arms
Number of subjects: 0
Study: 36371942

Group type: EXPERIMENTAL
Intervention: Binaural music
Number of subjects: 189

Group type: COMPARATOR
Intervention: Plain music
Number of subjects: 189

Group type: COMPARATOR
Intervention: No music
Number of subjects: 189
Study: 33660178

Group type: EXPERIMENTAL
Intervention: Municipal wastewater (MW) irrigation
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Remediated wastewater (RW) irrigation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Tap water (TW) irrigation
Number of subjects: 100
Study: 32074106

Group type: EXPERIMENTAL
Intervention: Exposure to attack advertisements
Number of subjects: 300
Study: 36201089

Group type: EXPERIMENTAL
Intervention: Biweekly TAS-102 (35 mg/m2 twice daily on days 1-5 and 15-19 in a 4-week cycle) and bevacizumab (5 mg/kg every 2 weeks)
Number of subjects: 44
Study: 33856729

Group type: EXPERIMENTAL
Intervention: Flaxseed supplementation (30 g/day ground flaxseed powder)
Number of subjects: 70
Study: 33255561

Group type: EXPERIMENTAL
Intervention: Maternal intake of docosahexaenoic acid (DHA) during pregnancy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maternal DHA intake during the third trimester
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maternal DHA intake during gestation and lactation
Number of subjects: 0
Study: 35192645

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (no interventions)
Number of subjects: 35
Study: 33180211

Group type: EXPERIMENTAL
Intervention: Productive failure learning condition
Number of subjects: 42

Group type: COMPARATOR
Intervention: Indirect failure learning condition
Number of subjects: 42
Study: 33334158

Group type: EXPERIMENTAL
Intervention: Peer‐led Group Lifestyle Balance (PGLB) intervention
Number of subjects: 314

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 314
Study: 32476236

Group type: EXPERIMENTAL
Intervention: Microencapsulated sodium butyrate (BLM)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 32576131

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion 0.25 μg/kg/min
Number of subjects: 180

Group type: COMPARATOR
Intervention: Remifentanil infusion 1ug/kg/min with propofol 50-150 ug/kg/min
Number of subjects: 180
Study: 33135384

Group type: EXPERIMENTAL
Intervention: LC-MS/MS method with direct dilute and shoot analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LC-MS/MS method after glucuronide hydrolysis
Number of subjects: 0
Study: 36056577

Group type: EXPERIMENTAL
Intervention: PSA < 1 ng/mL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PSA 1.0-1.99 ng/mL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PSA 2-2.99 ng/mL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Risk-stratification and re-screening intervals
Number of subjects: 0
Study: 33540206

Group type: EXPERIMENTAL
Intervention: Adaptive Disclosure (AD)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Cognitive Processing Therapy – Cognitive Therapy version (CPT-C)
Number of subjects: 122
Study: 35555185

Group type: EXPERIMENTAL
Intervention: Acipimox (50 mg/kg/day)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 64
Study: 32757413

Group type: EXPERIMENTAL
Intervention: Nabilone (median dose = 0.75 mg)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47

Group type: COMPARATOR
Intervention: Comparison between nabilone and placebo
Number of subjects: 47
Study: 35854238

Group type: EXPERIMENTAL
Intervention: Telephone counselling (up to six proactive phone calls over approximately six weeks)
Number of subjects: 910

Group type: COMPARATOR
Intervention: Self-help brochure (control condition)
Number of subjects: 910

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 910

Group type: EXPERIMENTAL
Intervention: Non-abstainers
Number of subjects: 910
Study: 34111359

Group type: EXPERIMENTAL
Intervention: Community Health Worker (CHW) services, 10 home visits
Number of subjects: 223

Group type: COMPARATOR
Intervention: Certified Asthma Educator (AE‐C) services, 2 in-clinic sessions
Number of subjects: 223
Study: 32928286

Group type: EXPERIMENTAL
Intervention: Hydrophobic polyurethane PICC with proximal valve
Number of subjects: 111

Group type: COMPARATOR
Intervention: Polyurethane PICC with external clamp (standard care)
Number of subjects: 111
Study: 35487685

Group type: EXPERIMENTAL
Intervention: Serum neurofilament light chain (sNfL) levels at baseline
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Age/body mass index-adjusted sNfL Z-scores
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Increase of 5.1 pg/mL in sNfL levels between baseline and 6 years
Number of subjects: 51
Study: 34932107

Group type: EXPERIMENTAL
Intervention: Multiorgan focused clinical ultrasonography (FCU) performed by an internal medicine physician in addition to standard clinical evaluation
Number of subjects: 248

Group type: COMPARATOR
Intervention: Standard clinical evaluation (Control)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Multiorgan focused clinical ultrasonography (FCU)
Number of subjects: 248
Study: 35435074

Group type: EXPERIMENTAL
Intervention: Spiritual Care students as full-time interdisciplinary team members during 12-week placements
Number of subjects: 16
Study: 33197395

Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose
Number of subjects: 1132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1132
Study: 33144354

Group type: EXPERIMENTAL
Intervention: Intensive glucose treatment
Number of subjects: 7275

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure (BP) intervention
Number of subjects: 7275

Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 7275
Study: 32052592

Group type: EXPERIMENTAL
Intervention: Brachio-basilic upper arm transposition fistula (BBAVF)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Prosthetic brachio-axillary vascular access grafts (BAPTFE)
Number of subjects: 60
Study: 2011528253

Group type: EXPERIMENTAL
Intervention: Monochromatic infrared energy (MIRE) therapy, daily for a total of 12 treatments
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 24
Study: 35537502

Group type: EXPERIMENTAL
Intervention: T2HIGH/T17LOW
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: T2LOW/T17HIGH
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: High FeNO levels
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Cystatin SN (CST1)
Number of subjects: 70
Study: 33486203

Group type: EXPERIMENTAL
Intervention: Overexpression of MeSCL30 in Arabidopsis
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Alternative splicing in cassava genes
Number of subjects: 15
Study: 32309857

Group type: EXPERIMENTAL
Intervention: HP rs2000999 G allele
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Haptoglobin level genetically predicted by HP rs2000999
Number of subjects: 540
Study: 34338348

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum 105 CFU/kg
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum 106 CFU/kg
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum 107 CFU/kg
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum 108 CFU/kg
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum
Number of subjects: 2400

Group type: COMPARATOR
Intervention: Control group (basal diet)
Number of subjects: 2400
Study: 34010530

Group type: EXPERIMENTAL
Intervention: Endovascular therapy
Number of subjects: 300

Group type: COMPARATOR
Intervention: Medical care
Number of subjects: 300
Study: 32779141

Group type: EXPERIMENTAL
Intervention: Daily SMS reminders with medication treatment
Number of subjects: 352

Group type: COMPARATOR
Intervention: Control group with 4-week medication treatment without reminders
Number of subjects: 352
Study: 36264431

Group type: COMPARATOR
Intervention: CRADLE trial cohort (n = 54)
Number of subjects: 554
Study: 33033864

Group type: EXPERIMENTAL
Intervention: Longer genetically predicted telomeres
Number of subjects: 417772

Group type: EXPERIMENTAL
Intervention: MR-Egger regression, weighted median, and weighted mode approaches
Number of subjects: 417772

Group type: EXPERIMENTAL
Intervention: MR-Egger regression
Number of subjects: 417772
Study: 35760319

Group type: EXPERIMENTAL
Intervention: Machine learning model using 68 preoperative factors to predict postoperative outcomes
Number of subjects: 848
Study: 32011497

Group type: EXPERIMENTAL
Intervention: pregabalin + electro-acupuncture (EA) treatment
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: pregabalin + Chuna manual therapy (CMT) treatment
Number of subjects: 90

Group type: COMPARATOR
Intervention: pregabalin administration
Number of subjects: 90
Study: 34256725

Group type: EXPERIMENTAL
Intervention: Peer-led health promotion intervention
Number of subjects: 57
Study: 32199584

Group type: EXPERIMENTAL
Intervention: Tranexamic acid treatment within 3 hours after the onset of acute bleeding
Number of subjects: 28333

Group type: EXPERIMENTAL
Intervention: Tranexamic acid treatment
Number of subjects: 28333
Study: 34962161

Group type: EXPERIMENTAL
Intervention: Gamified group (with narrative context and rewarding system)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Nongamified group (with no narrative context or rewarding system)
Number of subjects: 283
Study: 32533015

Group type: EXPERIMENTAL
Intervention: Oral hygiene products containing stannous ions (TG)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 16
Study: 34653398

Group type: EXPERIMENTAL
Intervention: Ketamine (subanesthetic dose)
Number of subjects: 14
Study: 35102968

Group type: EXPERIMENTAL
Intervention: Probiotic curd (Amul's Probiotic Dahi) containing Lactobacillus acidophilus (La5) and Bifidobacterium lactis (Bb12), 100 g two times a day for 21 days
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 62
Study: 35728909

Group type: EXPERIMENTAL
Intervention: Telepharmacy care group (customised mobile application and monthly telecommunications)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Usual care group (community pharmacists service)
Number of subjects: 256
Study: 32111199

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) sessions, 2 sessions completed
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) sessions
Number of subjects: 16
Study: 32713561

Group type: EXPERIMENTAL
Intervention: Intradialytic exercise (twice a week for 8 weeks)
Number of subjects: 64
Study: 35093130

Group type: EXPERIMENTAL
Intervention: Foot and ankle mobilisations combined with home stretches for a 6-week period
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Foot and ankle mobilisations combined with home stretches
Number of subjects: 16
Study: 33111239

Group type: EXPERIMENTAL
Intervention: Provider detection of nicotine use disorder
Number of subjects: 1076

Group type: EXPERIMENTAL
Intervention: Provider detection of cannabis use disorder
Number of subjects: 1076

Group type: EXPERIMENTAL
Intervention: Provider detection of alcohol use disorder among male patients
Number of subjects: 1076

Group type: EXPERIMENTAL
Intervention: Provider detection of alcohol use disorder among Black patients compared to White patients
Number of subjects: 1076

Group type: EXPERIMENTAL
Intervention: Provider detection of opioid use disorder among Black patients compared to White patients
Number of subjects: 1076

Group type: EXPERIMENTAL
Intervention: Provider detection of alcohol use disorder among Hispanic patients compared to White patients
Number of subjects: 1076

Group type: EXPERIMENTAL
Intervention: Provider detection of cocaine use disorder among Hispanic patients compared to White patients
Number of subjects: 1076

Group type: EXPERIMENTAL
Intervention: Provider detection rates based on addiction severity
Number of subjects: 1076
Study: 33583214

Group type: EXPERIMENTAL
Intervention: Nitrofurantoin
Number of subjects: 1
Study: 32363929

Group type: EXPERIMENTAL
Intervention: Axitinib
Number of subjects: 72
Study: 35024908

Group type: EXPERIMENTAL
Intervention: Training program on the cognitions and perceptions of workers with a chronic disease
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 59
Study: 33059105

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1000 mg in 200 mL normal saline)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Epinephrine (1 mg in 200 mL normal saline)
Number of subjects: 60
Study: 36308504

Group type: EXPERIMENTAL
Intervention: 5 min of Qigong practice (verum Qigong group, n = 15)
Number of subjects: 55

Group type: COMPARATOR
Intervention: 5 min of watching a wildlife video (negative control group, n = 15)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: 5 min of Qigong practice (Qigong-practitioner group, n = 25)
Number of subjects: 55
Study: 33807745

Group type: EXPERIMENTAL
Intervention: Protein supplementation
Number of subjects: 323

Group type: COMPARATOR
Intervention: Carbohydrate supplementation (placebo)
Number of subjects: 323
Study: 32265240

Group type: EXPERIMENTAL
Intervention: Strict implementation of the KDIGO bundle
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Compliance with the protocol
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Occurrence of any AKI and moderate/severe AKI
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Renal recovery at day 90
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Use of renal replacement therapy (RRT)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Mortality at days 30, 60 and 90
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Major adverse kidney events
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Safety outcomes
Number of subjects: 280
Study: 35190080

Group type: EXPERIMENTAL
Intervention: MyTeachingPartner (MTP) coaching; specific dosage not mentioned; duration not specified.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified; no direct comparison mentioned.
Number of subjects: 0
Study: 34471542

Group type: EXPERIMENTAL
Intervention: Personalized, temperature-reduced dialysate protocol
Number of subjects: 13500

Group type: COMPARATOR
Intervention: Fixed dialysate temperature of 36.5°C
Number of subjects: 13500
Study: 36002956

Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation intervention (specific details not provided)
Number of subjects: 28
Study: 32713847

Group type: EXPERIMENTAL
Intervention: Teaching Recovery Techniques (TRT) programme
Number of subjects: 226

Group type: COMPARATOR
Intervention: Services as usual (waitlist-control)
Number of subjects: 226
Study: 33416918

Group type: EXPERIMENTAL
Intervention: Oral anticoagulation therapy with vitamin-K antagonists
Number of subjects: 6637

Group type: EXPERIMENTAL
Intervention: Oral anticoagulation therapy with direct oral anticoagulants
Number of subjects: 6637

Group type: COMPARATOR
Intervention: Antiplatelet therapy alone
Number of subjects: 6637
Study: 35546279

Group type: EXPERIMENTAL
Intervention: Dulaglutide 1.5mg
Number of subjects: 9876

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9876
Study: 34039182

Group type: EXPERIMENTAL
Intervention: Corneal Crosslinking (CXL)
Number of subjects: 23
Study: 34129396

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 20
Study: 34842775

Group type: EXPERIMENTAL
Intervention: Low-Dose External Beam Radiotherapy (LD-EBRT) 6 × 0.5 Gy
Number of subjects: 25
Study: 33328187

Group type: EXPERIMENTAL
Intervention: Combination of 2.5 mg intravitreal bevacizumab and subconjunctival Mitomycin C (group A)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Subconjunctival Mitomycin C alone (group B)
Number of subjects: 56
Study: 34004448

Group type: EXPERIMENTAL
Intervention: L-arginine supplementation (9 g/day for 2 weeks)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study: 32699906

Group type: EXPERIMENTAL
Intervention: Wearing MOPP gear
Number of subjects: 49

Group type: COMPARATOR
Intervention: Not wearing MOPP gear
Number of subjects: 49